Bioterrorism: Thinking the unthinkable

Lancet

Volumn 351, Issue 9113, 1998, Pages 1378-

  Wise, R ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTHRAX; BIOLOGICAL WARFARE; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; UNITED STATES;

EID: 18344411265     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)79441-1     Document Type: Note

References (7)

1. Improving civilian medical response to chemical or biological terrorist incidents 1998 National Academy Press Washington DC
2. MI Chevrier The threat that won't disperse Washington Post Dec. 21, 1997 C1
3. AF Kaufmann MI Meltzler GP Schmid The economic impact of a bioterrorist attack Emerging Infectious Dis 3 1997 83 94
4. Boyce N. Nowhere to hide. New Scientist 158: 2127 p4.
5. Eitzen E. Medical preparedness for bioterrorism. International Conference on Emerging Infectious Diseases. March 8–11, 1998, Atlanta. Abstr no p 19.1.
6. Woodall JP. Assessing the risk to civilians after biological attack: the need for international technology transfer. International Conference on Emerging Infectious Diseases. March 8–11, 1998, Atlanta. Abstr no p19.2.
7. R Steffen J Melling JP Woodall Preparation for emergency relief after biological warfare J Infect 34 1997 27 32